Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | DTRMWXHS-12 |
Trade Name | |
Synonyms | DTRM-12|DTRMWXHS 12 |
Drug Descriptions |
DTRMWXHS-12 inhibits BTK, resulting in decreased B-cell receptor (BCR) signaling and potentially leading to reduced tumor cell growth (NCI Drug Dictionary). |
DrugClasses | BTK inhibitor 37 |
CAS Registry Number | NA |
NCIT ID | C130001 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
DTRMWXHS-12 | DTRMWXHS-12 | 0 | 1 |
DTRMWXHS-12 + Everolimus | DTRMWXHS-12 Everolimus | 0 | 1 |
DTRMWXHS-12 + Everolimus + Pomalidomide | DTRMWXHS-12 Everolimus Pomalidomide | 0 | 2 |